Table 1.
Characteristics of the study population.
| Patients with RAS Mutation | Patients with Wild-Type | All Patients | |
|---|---|---|---|
| Patients Description | Numbers (%)/Range | ||
| Gender | Men 15 (53.6%) | Men 12 (50.0%) | Men 27 (51.9%) |
| Women 13 (46.4%) | Women 12 (50.0%) | Women 25 (48.1%) | |
| Age | 58 y; range: 36–79 y | 59 y; range: 37–80 y | 59 y; range: 36–80 y |
| Primary Cancer Site | |||
| Colon | 15 (53.6%) | 13 (54.2%) | 28 (53.8%) |
| Rectum | 13 (46.4%) | 11(45.8%) | 24 (46.2%) |
| Hepatic Metastases Description | |||
| Patients with single nodule | 11 (39.3%) | 9 (37.5%) | 20 (38.5%) |
| Patients with multiple nodules | 17 (60.7%) | 15(62.5%) | 32 (61.5%)/range: 2–15 metastases |
| Nodule size (mm) | mean size 35.2 mm; range 19–54 mm | mean size 33.7 mm; range 18–52 mm | mean size 34.4 mm; range 18–54 mm |